Trials / Completed
CompletedNCT02040792
A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2B, 28-Day, Randomized, Double-Blind Placebo-Controlled Parallel Group Study of Nebulized TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 355 (actual)
- Sponsor
- Mylan Inc. · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluated the safety and efficacy of four doses of TD-4208 and a placebo product when administered once daily for 28 days using a jet nebulizer to patients with moderate to severe chronic obstructive pulmonary disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TD-4208 | |
| DRUG | Placebo |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2014-07-01
- Completion
- 2014-08-01
- First posted
- 2014-01-20
- Last updated
- 2022-02-24
- Results posted
- 2016-12-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02040792. Inclusion in this directory is not an endorsement.